Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervic… (NCT07508410) | Clinical Trial Compass
RecruitingNot Applicable
Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache
Turkey (Türkiye)90 participantsStarted 2025-12-01
Plain-language summary
Cervicogenic headache (CBH) is defined as a headache caused by a disorder in the cervical spine, bones, discs, or soft tissue elements, which is also accompanied by neck pain.
Unilateral, non-reversible oculo, fronto, temporal pain, pain that increases with poor neck positioning and incorrect neck movements, and may be seen with restricted movement in the upper cervical and occiput regions.
The aim of this thesis is to compare the effectiveness of Mulligan mobilization technique and myofascial release methods used in the treatment of cervicogenic headache through a prospective clinical study.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* Individuals aged 18-65
* Having experienced neck or headache for 3 months
* Meeting the diagnostic criteria for cervicogenic headache;
* Unilateral pain
* Reduced range of motion in the neck
* Ipsilateral shoulder discomfort
* Ipsilateral arm discomfort
* Pain that worsens with different neck movements and is painful on palpation
Exclusion criteria:
* Migraine
* Cluster headache
* Cervical radiculopathy
* Entrapment neuropathy
* Myelopathy
* Rheumatoid arthritis
* Undergoing cervical spinal surgery
* Pregnant women
* Those who received physical therapy within 6 months
* Those with a history of major psychiatric illness
* Those with a history of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological)
* Those with a history of uncontrolled systemic endocrine diseases (dm, hyperthyroidism)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Frequency of cervicogenic headache
Timeframe: Beginning, week 4, and week 8
2
assessment of pain intensity VAS pain (0-10)
Timeframe: Beginning, week 4, and week 8
Trial details
NCT IDNCT07508410
SponsorKonya Beyhekim Training and Research Hospital